Literature DB >> 2905599

Stereoselective blockade of alpha-adrenoceptors by berbine derivatives.

C Schott1, L Tetsi, C Heitz, J F Stambach, L Jung, J C Stoclet.   

Abstract

The effects of the two enantiomers of berbine (5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine) and of derivatives obtained by introducing various substitutions on aromatic rings were investigated on alpha 1- or alpha 2-adrenoceptor subtypes. Binding studies carried out on rat cerebral cortex membranes using [3H]prazosin or [3H]yohimbine showed that the affinities of the (+) and (-)enantiomers for alpha 1 and alpha 2 binding sites were different and were differently modified by substitutions added to the berbine nucleus, leading to alpha 1- and alpha 2-selective compounds. Experiments performed on the isolated rat aorta and in pithed rats in vivo demonstrated the alpha-blocking property of berbine derivatives and confirmed the stereoselectivity of the effects of the (+) and (-)enantiomers on alpha 1- and alpha 2-adrenoceptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905599

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.

Authors:  M D Ivorra; C Lugnier; M Catret; E Anselmi; D Cortes; P D'Ocon
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

2.  Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.

Authors:  M D Ivorra; C Lugnier; C Schott; M Catret; M A Noguera; E Anselmi; P D'Ocon
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

3.  Mechanism of the cardiovascular activity of laudanosine: comparison with papaverine and other benzylisoquinolines.

Authors:  S Chuliá; M D Ivorra; C Lugnier; E Vila; M A Noguera; P D'Ocon
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.